Synergistic antibacterial activity of PEGylated silver–graphene quantum dots nanocomposites  by Habiba, Khaled et al.
S
n
K
V
G
a
b
c
d
e
f
g
h
a
A
R
R
A
K
G
A
N
T
S
1
a
d
D
a
c
P
h
2Applied Materials Today 1 (2015) 80–87
Contents lists available at ScienceDirect
Applied  Materials  Today
j ourna l ho me  page: www.elsev ier .com/ locate /apmt
ynergistic  antibacterial  activity  of  PEGylated  silver–graphene  quantum  dots
anocomposites
haled  Habibaa,b,∗,  Dina  P.  Bracho-Rinconb,c, Jose  A.  Gonzalez-Felicianob,c, Juan  C.  Villalobos-Santosb,d,
ladimir  I.  Makarova, Darinel  Ortizd, Javier  A.  Avalosb,e, Carlos  I.  Gonzalezb,c,f,g, Brad  R.  Weinerb,g,h,
erardo  Morell a,b,g
Department of Physics, University of Puerto Rico – Rio Piedras Campus, San Juan, PR 00936-8377, USA
Molecular Sciences Research Center, University of Puerto Rico, 1390 Ponce de Leon Ave., STE. 2, San Juan, PR 00926-2614, USA
Department of Biology, University of Puerto Rico – Rio Piedras Campus, San Juan, PR 00931-3360, USA
Department of Biology, University of Puerto Rico – Bayamon Campus, Bayamon, PR 00959, USA
Department of Physics, University of Puerto Rico – Bayamon Campus, Bayamon, PR 00959, USA
Department of Biochemistry, University of Puerto Rico – Medical Sciences, San Juan, PR 00936-5067, USA
Institute for Functional Nanomaterials, University of Puerto Rico, San Juan, PR 00931-3334, USA
Department of Chemistry, University of Puerto Rico – Rio Piedras Campus, San Juan, PR 00931-3346, USA
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 4 August 2015
eceived in revised form 5 October 2015
ccepted 5 October 2015
eywords:
raphene quantum dots
ntibacterial nanoparticles
anocomposites
oxicity
ilver nanocomposites
a  b  s  t  r  a  c  t
The  emergence  of  antibiotic-resistant  bacteria  is a major  threat  to world-wide  public  health.  Function-
alized  nanoparticles  could  offer  novel  strategies  in  this  post-antibiotic  era. In  this study,  we  developed
nanocomposites  of silver  nanoparticles  decorated  with  graphene  quantum  dots  (Ag-GQDs)  using  pulsed
laser  synthesis.  The  nanocomposites  were PEGylated,  which  increases  their biocompatibility  and  solu-
bility  in  aqueous  solutions.  The  HR-TEM  micrographs  of bare  GQDs  show  that  their size  is in the  range  of
1.6–4 nm,  and  the lattice  spacing  is  0.214  nm,  which  corresponds  to the (1 0 0)  lattice  fringes  of graphene.
The  antibacterial  activity  of  Ag-GQDs  was  evaluated  and  compared  to that  of  bare  GQDs  and  commercial
silver  nanoparticles  (Ag-NPs)  against  both  Gram-negative  and  Gram-positive  bacteria,  using  Pseudomonas
aeruginosa  and  Staphylococcus  aureus  as  model  bacteria,  respectively.  Concentration  values  of  25  and
50 g/mL  are  required  for Ag-GQDs  to inhibit  the growth  of  S. aureus  and  P.  aeruginosa  bacteria,  respec-
tively.  The  fractional  inhibitory  concentration  (FIC) index  is below  0.5  indicating  that  there  is a synergistic
effect  between  Ag-NPs  and  GQDs.  Kirby–Bauer  tests  showed  that  Ag-GQDs  inhibit  P.  aeruginosa  and  S.
aureus,  in  contrast  to bare  GQDs  and  Ag-NPs  alone.  Cell  viability  of  normal  mammalian  cells  treated
with  Ag-GQDs  showed  that cell  viability  is  maintained  at 100%  for cells  incubated  with  Ag-GQDs.  The
decoration  of  Ag-NPs  with  GQDs  minimizes  their  cytotoxicity  in mammalian  cells  and  increases  their  bio-
compatibility.  Ag-GQDs  have  potential  applications  in  the  fabrication  of antibacterial  coatings,  self-sterile
textiles,  and  personal  care  products.
© 2015  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license. Introduction
Microbial infections are considered a major health problem with
 growing concern toward those that do not respond to treatment
ue to antibiotic-resistant bacteria. According to the U.S. Centers for
isease Control and Prevention, approximately two million people
re infected annually with bacteria resistant to antibiotics, of which
a. 23,000 people die as a direct result of these infections [1]. The
∗ Corresponding author at: Department of Physics, University of Puerto Rico, Rio
iedras Campus, San Juan, PR 00936-8377, USA.
E-mail addresses: khabiba@gmail.com, khaled.habiba@upr.edu (K. Habiba).
ttp://dx.doi.org/10.1016/j.apmt.2015.10.001
352-9407/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
prevention and treatment of these infections has drawn consider-
able attention and presents a critical challenge to develop drugs,
antibiotics and/or antibacterial substances able to inhibit bacterial
growth.
Infections due to Pseudomonas aeruginosa (P. Aeruginosa) and
Staphylococcus aureus (S. aureus) have been documented in surgical
sites, where they have been attributed to dermal injuries and burn
wounds [2]. Gram-negative bacteria are characterized by a lipid-
rich outer membrane as well as a plasma membrane and a thin
peptidoglycan layer, while Gram-positive bacteria are enshrouded
in thicker, more resilient cell walls [3]. This difference in cell wall
is important for antibiotic development, since bacterial resistance
might be due in part to cell wall composition [4].
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Several traditional antibacterial agents, such as: tetracycline,
treptomycin, and sulfonamides, have been developed to inhibit
acterial infections. However, these antibiotics have failed to
nhibit many types of bacteria and multidrug-resistant strains have
ppeared due to the pathogen’s evolution in counteracting the bio-
idal action of the agent molecules [5]. Consequently, it is necessary
o develop antibacterial agents that can overcome the limitations
f common traditional antibacterial agents and preferably work
gainst both types of bacteria. Emerging materials such as: silver
anoparticles (Ag-NPs) [6–13], copper oxide nanoparticles [13,14],
arbon nanomaterials [15–20], and metal oxide nanoparticles [21],
ave been reported as antimicrobial agents. Speciﬁcally, silver is
idely recognized for its capacity to kill bacteria and have been
onsidered for use in wound infections and in the clothing indus-
ry [13,22,23], and products containing silver nanoparticles such
s Acticoat wound dressing and I-Flow catheter were approved
y the FDA [24]. Chemical and physical factors associated with
g-NPs such as: their size [6,7], shape and surface charge [25]
nhance their antibacterial properties and affect signiﬁcantly the
ffective doses to inhibit bacterial growth. The mechanism of Ag-
Ps as an antibacterial agent is not totally clear, but some possible
echanisms has been reported include: denaturation of the 30s
ibosomal subunits [12], inhibition of respiratory enzymes [12,26],
inding and dimerization of RNA and DNA [11], and disruption
f the outer membrane [9]. Nevertheless, commercially available
ilver-based dressings have shown cytotoxic effects on various
xperimental models [10,27]. The synthesis of silver nanocom-
osites may  be a potential solution to enhance the antibacterial
ctivities of Ag-NPs and to overcome the adverse toxic effects
f silver by optimizing the concentration of Ag. One approach to
ynthesize silver nanocomposites is to use carbon-based nanoma-
erials such as: graphene [28], carbon nanotubes (CNTs) [29–33],
nd graphene oxide with low concentrations of silver [33–37]. Seo
t al. reported the synthesis and use of silver-CNTs complexes
s antibacterial material [31]. Dong et al. showed that there is
 synergistic effect between Ag-CNTs nanocomposites and oxi-
izing agents such (i.e., H2O2 and NaOCl) when they are used in
ombination to treat Gram-positive and Gram-negative bacteria
29]. However, CNTs might be toxic due to their contamination
ith metallic catalysts used in their synthesis [36], and many
eports have shown their potential hazards against mammalian
ells [38–42]. Poland et al. reported that CNTs could be a poten-
ial carcinogenic material, and may  lead to mesothelioma [41].
iu et al. found that CNTs increase the intracellular reactive oxy-
en species (ROS), and can react with cellular macromolecules
ncluding DNA, proteins, and lipids and disturb the homeostasis of
he intracellular milieu [40]. Graphene oxide–silver nanocompos-
te has also demonstrated antibacterial activity against Escherichia
oli and S. aureus,  however, they showed toxic effect against
ammalian cells [43]. Therefore, there still much efforts needed
nd challenges to optimize these nanocomposites prior clinical
se.
Graphene quantum dots (GQDs) are among the carbon nano-
tructures that may  be good candidates for biomedical applications
ue to their solubility in aqueous solutions and high biocompati-
ility. GQDs are nanostructures of graphene in the size range of
–20 nm with a set of excellent and unique chemical and physical
roperties [19,20,44–53]. In general, GQDs have no apparent tox-
city [44,48,50,52], and they have demonstrated high potential for
tilization in cellular imaging [46–48,52], as antibacterial material
19,20], and drug delivery [53]. Chong et al. studied their toxic-
ty and biodistribution in vitro and in vivo, and analysis of WST-1
ssay, cell apoptosis, LDH production and ROS level clearly demon-
trated good biocompatibility of GQD and GQD-PEG at cellular level
44]. Nurunnabi et al. showed that carboxylated GQDs do not cause
pparent toxicities in rats at different dosage (5 and 10 mg/kg) forals Today 1 (2015) 80–87 81
22 days as evidenced by blood biochemistry and hematological
analysis [48].
Another proposed strategy to reduce the cytotoxicity of
nanoparticles is the PEGylation of their surface [54]. The PEGy-
lation is a process that involves the passivation of the surface of
nanoparticles by polyethylene glycol (PEG), a coiled polymer PEG
is a polymer of repeating ethylene ether units soluble in water and
aqueous solutions, which reduce the tendency of nanoparticles to
agglomeration and their interaction reticuloendothelial system i.e.,
macrophages and monocyte, and increase their circulation time in
blood. Interestingly, Marslin et al. reported that membrane perme-
abilizing nature of PEG would facilitate the entry of nanoparticles
carrying antibiotics, enhance the binding of the delivered drug to
the bacterial DNA and block drug efﬂux pumps [55]. We  report
hereby the synthesis of PEGylated Ag-GQDs nanoparticles and a
study of their cell toxicity and antibacterial properties. By decorat-
ing Ag-NPs with GQDs, it is anticipated that the resulting Ag-GQDs
can be tailored to be an efﬁcient and a safe antibacterial material.
2. Materials and methods
2.1. Synthesis of the bare GQDs
For the synthesis of bare GQDs, we  used our bottom-up syn-
thesis approach as described previously [46]. To functionalize the
synthesized bare GQDs with polyethylene glycol (PEG), we  modi-
ﬁed the irradiated mixture as follows. A 0.25 wt.% mixture of nickel
oxide powder (Alfa Aesar) and 1.25 wt.% of PEG bis (3-aminopropyl)
terminated (Sigma–Aldrich) in 98.5 wt.% benzene (Sigma–Aldrich)
was irradiated for 45 min with a 1064 nm pulsed Nd:YAG laser
(Continuum Surelite II, KDP doubling crystal, 10 Hz, 10 ns pulse
width). The synthesized GQDs were separated from benzene and
the precipitated nickel oxide by centrifugation at 10,000 rpm, after
being dissolved in nano-pure water. Finally, the GQDs solution
was puriﬁed using dialysis bags with a cut-off molecular weight
(MWCO) of 6–8 kDa (Spectrum Labs, USA).
2.2. Synthesis of the bare GQDs and Ag-GQDs
For synthesis of Ag-GQDs, we  have employed our approach
to synthesize GQDs by pulsed laser [56] with minor modiﬁ-
cations. Brieﬂy, a mixture of 0.25 wt.% of silver powder (silver
nanopowder No. 576832, Sigma–Aldrich) and 1.25 wt.% of PEG
bis(3-aminopropyl) terminated (Sigma–Aldrich) in 98.5 wt.% ben-
zene (Sigma–Aldrich) was prepared and irradiated by pulsed laser.
After irradiation a mixture of GQDs and Ag-GQDs is formed in
benzene. The synthesized nanoparticles were separated from ben-
zene by vacuum evaporation and dissolved in nano-pure water,
upon centrifugation at 10,000 rpm to precipitate the Ag-GQDs. After
centrifugation, the Ag-GQDs were separated from free GQDs and
excess of PEG by using dialysis bags with a cut-off molecular weight
(MWCO) of 12–14 kDa (Spectrum Labs, USA).
2.3. Instrumentation and measurements
High transmission electron microscopy (HR-TEM) images were
recorded using an electronic microscope (JEOL JEM-2200FS, Japan),
operated at 200 kV in scanning transmission electron microscope
(STEM) mode. XPS experiments were performed with Physical
Electronics Instruments (PHI-Quantum 2000, USA), using Al K
source. XRD patterns were performed with a powder diffractome-
ter (Rigaku Smart-lab, Japan), equipped with a Cu K radiation
source, at an accelerating potential of 40 kV and a tube current of
44 mA.  The XRD samples were prepared by placing a certain pow-
der amount of: bare GQDs, silver, or Ag-GQDs on silicon substrates.
The hydrodynamic size of the Ag-GQDs nanocomposites and bare
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ilver nanoparticles were determined by dynamic light scattering
DLS) using a (Malvern Zetasizer Nanoseries, UK). The samples were
ispersed in phosphate buffered saline solution (PBS) at 7.4.
.4. Antibacterial tests
The antibacterial properties of the nanomaterials were tested
gainst P. aeruginosa bacteria (ATCC 27853) and S. aureus bacteria
ATCC 25923). The inoculum for antibacterial assays was prepared
rom actively growing organisms (logarithmic phase). The inocu-
um of S. aureus and P. aeruginosa were prepared from an overnight
ulture grown aerobically in Mueller–Hinton (MH) broth at 37 ◦C.
he bacterial concentration was determined by measuring optical
ensity at 600 nm (OD600).
.4.1. The microdilution method
The bacterial minimum inhibitory concentration (MIC) for Ag-
QDs and GQDs were determined based on the broth microdilution
ethods, as described in the Clinical laboratory standards guide-
ines with minor modiﬁcations [57]. MIC  is deﬁned as the lowest
oncentration of an antimicrobial that will inhibit the visible
rowth of a microorganism after overnight incubation [58]. Brieﬂy,
acterial suspensions were prepared from overnight cultures and
djusted to 106 CFU/mL. Then, a 100 L of fresh MH  broth, 40 L of
acterial suspension and 60 L of different concentrations of Ag-
QDs (1, 2, 25, 50, 100, 150, 200, 400 g/mL), bare Ag-NPs (1, 2,
5, 50, 100, 150, 200 g/mL) and bare GQDs (50, 100, 500, 700
nd 900 g/mL) were added in 96-well plate. A positive growth
ontrol of basal medium without nanoparticles was  included to
valuate the viability of the tested organisms. The microplates
ere incubated aerobically at 37 ◦C for 24 h under linear shak-
ng. Finally, the MIC  value was determined by observing the wells
orresponding to the lowest concentration inhibiting the bacterial
rowth. To determine if there is a synergistic effect between the
QDs and Ag-NPs in the Ag-GQDs nanocomposites, we  applied the
ractional inhibitory concentration (FIC) test [59]. The combined
ntibacterial effect of nanoparticles A and B (where A is Ag-NPs,
 is GQDs, and AB is Ag-GQDs) was calculated as follows: the
IC index = [MIC(AB)/MIC(A)] + [MIC(AB)/MIC(B)]. FIC index values
bove 2.0 indicate antagonistic effects, values between 0.5 and 2.0
ndicate additive effects, and values lower than 0.5 indicate syner-
istic effects. Note that we calculated the upper bound of the FIC
ndex because we have available the lower bounds of MIC(A) and
IC(B).
.4.2. Time-dependent growth inhibition assay
The bacterial population growth rate of bacteria treated with
g-GQDs, GQDs or Ag-NPs was analyzed using the microplate
eader (Biotek Synergy H4 Hybrid, Winooski, VT, USA). Bacterial
uspensions were prepared from overnight cultures and adjusted to
06 CFU/mL. A 100 L of fresh MH broth, 40 L of bacterial suspen-
ion and 60 L of different concentrations of Ag-GQDs (10, 25, 50,
00 and 150 g/mL), bare Ag-NPs (10, 25, 50, 100 and 150 g/mL),
r GQDs (50, 100, 500, 700 and 900 g/mL) were added in the
6-well microplate. For positive growth controls, 60 L of nanopar-
icles were replaced with the solvent used to dissolve nanoparticles
hosphate buffer saline (PBS). The absorbance was  measured at
D600 at intervals of 20 min  for a total period of 22 h.
.4.3. The Kirby–Bauer disk diffusion method
The antimicrobial susceptibility of Ag-GQDs nanoparticles was
valuated using the Kirby–Bauer disk diffusion method [57]. In
rief, a bacterial inoculum with a turbidity equivalent to 0.5 Mac-
arland was inoculated evenly onto the surface of MH agar in Petri
ishes by swabbing. Sterile ﬁlter paper disks were impregnated
ith GQDs (100 g/disk), bare Ag-NPs (50 and 100 g/disk), orals Today 1 (2015) 80–87
Ag-GQDs (50 and 100 g/disk) and then deposited on the agar
surface. For positive inhibition controls, disks of commercial antibi-
otics of streptomycin (10 g/disk) and ampicillin (30 g/disk) were
used against S. aureus,  and for P. aeruginosa disks of streptomycin
(10 g/disk) and tetracycline (30 g/disk) were used. For negative
inhibition controls, disks were impregnated with sterile PBS. The
zones of inhibition were measured after 24 h of incubation at 37 ◦C.
2.4.4. SEM imaging of P. aeruginosa treated with Ag-GQDs
Prior to SEM analysis, samples of bacteria treated with Ag-
GQDs, and untreated bacteria were prepared. Brieﬂy, a drop of P.
aeruginosa (106 CFU/mL) incubated with Ag-GQDs (25 g/mL) or
untreated bacteria was deposited on the surface of a sterile cover
glass and incubated for 24 h at 37 ◦C inside an empty Petri dish. Both
samples were dried and covered with a gold ﬁlm of 10 nm using an
Auto Sputter Coater Pelo SC-7. Finally, the samples were imaged
with a FE-SEM (JEOL JSM-7500F, Japan) at an acceleration voltage
of 15 kV.
2.5. Cell culture
HeLa cells were cultured in Eagle’s minimum essential medium
(ATCC) supplemented with 10% fetal bovine serum (ATCC),
100 U/mL penicillin, 100 g/mL streptomycin and 250 ng/mL
amphotericin B (Cellgro) at 37 ◦C with 5% CO2.
Vero cells (African green monkey kidney epithelial cells;
obtained from the Center for Disease Control and Prevention-
Dengue Branch) were maintained in M199 medium (Mediatech)
containing 5% heat-inactivated FBS, 1% sodium bicarbonate, 1%
HEPES buffer, 1% glutamine and 1% penicillin–streptomycin at 5%
CO2 and 37 ◦C.
Jurkat cells were cultured in RPMI (ATCC) supplemented with
10% fetal bovine serum (ATCC), 100 U/mL penicillin, 100 g/mL
streptomycin and 250 ng/mL amphotericin B (Cellgro) at 37 ◦C with
5% CO2.
2.6. MTS  cell viability assay
The cell viability effects of GQDs, Ag-NPs and Ag-GQDs
nanoparticles were assessed on Vero cells by using the
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium)-based (MTS) CellTiter 96® AQueous
Solution Cell proliferation Assay (Promega, USA). 2 × 104 cells
were seeded in 96-well plates (Falcon) and grown overnight.
After 24 h, the cell culture medium was  removed and 100 L of
complete cell medium containing Ag-GQDs, Ag-NPs or GQDs at
the concentrations (25, 50, 100, 150 g/mL) were added. Fresh
culture medium was  used as a negative control. After 24 h of cell
incubation, the medium was  discarded and 100 L of fresh cell
medium with 20 L of MTS  reagent was added. Then, the cells
were incubated for 30 min  at 37 ◦C and centrifuged at 1400 rpm for
5 min. Subsequently, the cell medium containing the MTS  reagent
was transferred to a new microplate and the absorbance at 490 nm
was measured with a UV–vis microplate spectrometer (Biotek
Synergy H4 Hybrid, Winooski, VT, USA).
Cell viability assays were assessed in Jurkat and HeLa cells
for Ag-GQDs nanoparticles at the concentrations (25, 50, 100 and
150 g/mL) using the (MTS) CellTiter 96® AQueous Solution Cell
proliferation Assay. For HeLa, 2 × 104 cells were seeded in 96-well
plates and for Jurkat 2 × 105 cells were seeded in 96-well plates
(Falcon) and grown overnight. Fresh culture medium was used
as a negative control. After 24 h of cells incubation, the medium
was discarded and 100 L of fresh cell medium with 20 L of
MTS  reagent was  added. Then, the cells were incubated for 30 min
at 37 ◦C and centrifuged at 1400 rpm for 5 min. Subsequently,
the cell medium containing the MTS  reagent was transferred to
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o  color in the text, the reader is referred to the web  version of this article.)
 new microplate and the absorbance at 490 nm was  measured
ith a UV–vis microplate spectrometer (Biotek Synergy H4 Hybrid,
inooski, VT, USA). For data analysis, the results were expressed
s % of cell viability. The equation used was the following:
 of cell viability = Abs490 of treated cells
Abs490 of untreated cells
× 100
.7. Statistical analysis
The experiments were performed in triplicates. The results were
xpressed as the mean of the standard deviation of values obtained
rom at least three independent experiments, differences in mean
etween control and bacteria treated with each nanoparticle were
nalyzed by Student’s t-test using GraphPad Prism 5 software and
p < 0.05) was considered statistically signiﬁcant.
. Results and discussion
.1. Characterization of Ag-GQDs
The synthesized Ag-GQDs nanocomposites were fully charac-
erized using microscopic and spectroscopic techniques, before
tudying its antibacterial activity. HR-TEM microscopy was
mployed to give information related to the size, morphology and
rystalline structure of Ag-GQDs. The HR-TEM micrographs of bare
QDs (Fig. 1A) depict their size range of 1.6–4 nm,  and lattice spac-
ng of 0.214 nm that corresponds to the (1 0 0) lattice fringes of
raphene [46,49]. Fig. 1B displays a single Ag-GQDs nanoparticle.Magniﬁed image of the Ag-GQDs cluster in dark-ﬁeld, which shows the Ag-GQDs
a in C, which shows GQDs inside the PEG shell. (For interpretation of the references
The nanocomposites shows a diameter of 10 nm with an inter-
planar spacing of 0.145 nm (pointed out in yellow) that matches
with the (2 2 0) plane of silver [32]. Some nanostructures were
observed on the surface of the Ag-NPs with a lateral diameter
of 1.6–2 nm and the same 0.214 nm (pointed out in white) inter-
planar spacing of graphene (1 0 0) shown in Fig. 1A. In order to
obtain more information about the nanocomposites, we  employed
the dark ﬁeld to get the high contrast of the clusters (Fig. 1C). The
image in the inset (Fig. 1C) shows clusters of nanoparticles in the
range of 50–70 nm and other nanoparticles less than 20 nm. It can
be clearly observed that the nanoparticles of silver and GQDs are
packed together forming the core, which is coated by the PEG shell.
Fig. 1D conﬁrms the presence of bare GQDs inside the PEG shell,
when the selected region in the dotted rectangle (Fig. 1C) was
magniﬁed.
XRD spectroscopy was analyzed to reveal the crystalline struc-
ture of Ag-GQDs and validate the HR-TEM characterization results.
XRD patterns were obtained for the bare GQDs, silver powder used
in the synthesis, and the Ag-GQDs (Fig. 2). In the XRD pattern of
silver, the peaks at 38.1◦, 44.3◦, 64.5◦ and 77.5◦ are assigned to the
crystallographic planes (1 1 1), (2 0 0), (2 2 0) and (3 1 1) of the face-
centered cubic (fcc) Ag nanoparticles, respectively, according to the
JCPDS card No. 04-0783. For the bare GQDs, the peak at 26.6◦ is
commonly observed and corresponds to the d-spacing of the basal
plane (0 0 2) of graphite [51]. The peaks shown at 18.97◦, 23.3◦ and
35.7◦ are attributed to PEG, which is conjugated on the surface of
bare GQDs, and match with the PEG peaks reported by El Moussaoui
et al. [60]. As expected, the combination of the observed peaks in
silver, PEG and GQDs in the XRD pattern arise in the pattern of
84 K. Habiba et al. / Applied Materials Today 1 (2015) 80–87
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Table 1
MIC  values of Ag-GQDs, bare GQDs and bare Ag-NPs required for inhibition of P.
aeruginosa and S. aureus.
Tested sample MIC (g/mL)
P. aeruginosa S. aureus
GQDs >900 >900
terial bioﬁlms. Commonly commercial antibiotics (i.e., ampicillin,
streptomycin, and tetracycline) were used as positive inhibition
control. Table 2 summarizes the diameter of the inhibition zones
exhibited by the diffusion of Ag-GQDs, Ag-NPs, bare GQDs and
Table 2
Inhibition zones evaluated using the Kirby–Bauer method for: negative control, bare
Ag-NPs, bare GQDs, Ag-GQDs and positive controls.
Tested sample Inhibition zone (mm)
P. aeruginosa S. aureus
Ag-GQDs (50 g/disk) 10 ± 1 15 ± 1
Ag-GQDs (100 g/disk) 24 ± 1 25 ± 0.5
GQDs (100 g/disk) – –Fig. 2. XRD patterns of Ag-GQDs, GQDs and silver powder.
g-GQDs nanocomposites. The XRD results are consistent with the
R-TEM data described above.
The XPS technique was employed to quantify the approximate
lemental composition attributed from silver and carbon in atomic
ercent (%). The XPS analyses indicate that the attribution of sil-
er and carbon are approximately 33 and 66%, respectively. The
econvolution of the high resolution XPS spectrum at C1s (Fig. 3A)
eveals the presence of amine, hydroxyl, ether and carboxyl groups
t 285.9, 286.7, 287.7 and 289.4 eV, respectively. Fig. 3B shows the
PS signature of the Ag 3d doublet (3d5/2 and 3d3/2) for the silver
n the Ag-GQDs. The analyses of Ag 3d shows the presence of two
g 3d doublets at 368.4 eV and 374.4 eV, and 369.8 eV and 375.8 eV,
espectively. It is clear that both doublets are shifted to higher bind-
ng energy compared to metallic silver (368.2 eV) [35,36], which
ay  be due to the electron transfer from metallic Ag to GQDs owing
o the smaller work function of Ag than graphene. For the second
esolved peak at 369.8 eV of the second doublet, the shift to higher
inding energy compared to metallic silver could be assigned to a
harge transfer between the silver and the polymer i.e.,  PEG coating
he nanocomposites [61].
The dispersion stability of Ag-GQDs was tested using the
ynamic light scattering (DLS) technique. The DLS spectrum of
he bare Ag-NPs (Fig. S1A) shows that they have a mean hydro-
ynamic diameter of 143.6 nm and the polydispersity index (PDI)
s 0.327, which indicates that they are polydisperse and their large
iameter is probably due to their tendency to agglomerate. On the
ther hand, the Ag-GQDs show a mean diameter of 33 nm and the
DI decreased i.e.,  0.095, as compared to the commercial Ag-NPs
Fig. S1B). The DLS data reveal that the PEGylation and the deco-
ation of silver nanoparticles with GQDs increase the stability of
ilver and decrease their agglomeration.
.2. Antibacterial activity tests
To evaluate the applicability of Ag-GQDs as an antibacte-
ial agent, we tested them at different concentrations against P.
eruginosa and S. aureus.  We  employed the microdilution method
o evaluate their antibacterial activity and to determine their mini-
um inhibitory concentration (MIC). The evaluation included also
ifferent concentrations of bare GQDs and Ag-NPs, in order to com-
are and analyze the antibacterial behavior contributed from each
omponent of the nanocomposites. Table 1 summarizes the MIC
alues of bare Ag-NPs, bare GQDs and Ag-GQDs to inhibit both bac-
erial strains. The obtained data show that a MIC  of 25 and 50 g/mL
f Ag-GQDs are required to inhibit the growth of S. aureus and P.
eruginosa bacteria, respectively. On the other hand, the MIC  cor-
esponding to bare Ag-NPs and GQDs were found to be above theAg-GQDs 50 25
Ag-NPs >200 >200
tested concentrations of both nanoparticles (i.e., >900 g/mL for
GQDs and >200 g/mL for Ag-NPs). It is clear that there is a signif-
icant enhancement and a strong antibacterial activity associated
with Ag-GQDs, as compared to bare Ag-NPs and GQDs.
We performed the fractional inhibitory concentration (FIC) test
to evaluate the synergism between Ag and GQDs [46]. We  took the
MIC  values of 200 and 900 g/mL as the lower bounds for Ag-NPs
and GQDs, respectively. The calculation gives an upper bound of
the FIC index value of 0.31 and 0.15 for P. aeruginosa and S. aureus,
respectively. According to Ruden et al. [59], a FIC index below 0.5
indicates synergy. Therefore, the results of the FIC test indicate that
there is a synergistic effect between Ag-NPs and GQDs.
Moreover, to study the antimicrobial effectiveness of Ag-GQDs,
dose-dependent growth kinetics curves of P. aeruginosa were used
to assess the relative rate and extent of antibacterial activity of
Ag-GQDs. Fig. S2A–C (see supplementary information) display the
growth proﬁles of P. aeruginosa treated with various concentrations
of bare Ag-NPs, GQDs, and Ag-GQDs. Fig. S2A shows a weak inhibi-
tion of P. aeruginosa when treated with bare Ag-NPs. The interaction
between GQDs and P. aeruginosa was even weaker than bare Ag-
NPs, and the inhibition was very low (see Fig. S2B). The highest
concentration of 200 g/mL induced a delay of 4 h in the growth
rate of P. aeruginosa. On the other hand, Ag-GQDs nanocompos-
ites displayed a considerably strong antibacterial behavior at lower
concentrations. The treatment of P. aeruginosa with a concentra-
tion of 25 g/mL induced a delay of 8 h in the bacterial population
growth rate, and no growth was observed at higher concentrations
for a period of 20 h.
We  carried out similar bacterial population growth kinet-
ics experiments for all tested nanoparticles with S. aureus (see
Fig. S3A–C). High resistance was observed from S. aureus to bare
Ag-NPs at all tested concentrations (see Fig. S3A). For bare GQDs,
a low antibacterial activity against S. aureus was  seen, where the
bacterial growth rate becomes slower when increasing the GQDs
concentrations. Nonetheless, an increase in the antibacterial effect
of Ag-GQDs was observed, where the bacterial population growth
was inhibited for at least 20 h at a concentration of 25 g/mL.
Furthermore, we  used the Kirby–Bauer method to evaluate the
ability of Ag-GQDs nanocomposites to inhibit the formation of bac-Ag-NPs (50 g/disk) – –
Ag-NPs (100 g/disk) – –
Streptomycin 10 ± 0.1 15 ± 1
Tetracycline or ampicillin 20 ± 2 35 ± 1
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tFig. 3. High resolution XPS spe
ommercial antibiotics against S. aureus and P. aeruginosa. Ag-
QDs inhibited both bacterial strains at both concentrations, and
he inhibition zones at the lowest concentration (50 g/disk) are
0 and 15 mm for P. aeruginosa and S. aureus,  respectively. In
ontrast, the bare GQDs and Ag-NPs did not exhibit any inhibition
gainst both bacterial strains.
.3. Proposed antibacterial mechanisms
Looking into the antibacterial activity of Ag-GQDs compared
o bare GQDs and Ag-NPs, and the corresponding FIC test results
escribed above, it is evident that the stronger antibacterial activ-
ty of Ag-GQDs arises from a synergistic effect between Ag-NPs
nd GQDs. To understand the origin of this synergistic effect, it
s essential to analyze the possible interactions between bacteria
nd systems similar to Ag-GQDs (i.e., Ag–CNTs, Ag–graphene, and
g–graphene oxide).
There are several suggested mechanisms describing the bac-
erial inhibition by silver–carbon nanocomposites that have been
roposed to explain the inhibition caused by Ag-GQDs. Kazmi et al.
30] suggest that the enhancement in the antibacterial proper-
ies of Ag-CNTs nanocomposites may  result from silver ions (Ag+)
ontributed by silver nanoparticles, which bind to thiol groups in
nzymes and proteins on the cellular surface and cause destabi-
ization of membranes and cellular walls. The size of the Ag-NPs
s an essential factor in their ability to inhibit bacteria, since their
IC  decreases when their size decreases [7,8]. This is due to the
urface-to-volume ratio, which increases as the size decreases, and
s consistent with the low antibacterial activity that we found for
ommercial bare Ag-NPs that aggregate into micron-scale clusters.
azmi et al. [30] also suggested that the adhesion of Ag-NPs and
NTs composites to the bacterial cell wall can produce holes and
llow the composite penetration inside the bacteria. The damage to
he cell wall of bacteria by Ag-CNTs nanocomposites may  also result
rom the interference in some physiological processes such as the
ownregulation of some genes associated with outer membrane
ntegrity of the Gram-negative Salmonella bacteria [62]. Moreover,
t was reported that nanostructures such as graphene, graphene
xide, CNTs and Ag-CNTs may  induce considerable damage to the
acterial cell walls by oxidative stress induced by oxygen radi-
als and/or cell membrane disruption by sharp edges of graphene
15,17,33,53]. In fact, we observed physical damage to P. aeruginosa
acteria treated with Ag-GQDs in the SEM images (see Fig. S4). In
ig. S4A, the SEM image of untreated P. aeruginosa bacteria depicts
heir typical rod shape and 1–3 m length. They underwent frag-
entation and deformation after treatment with Ag-GQDs (see
ig. S4B). Akhavan et al. found that the cell membrane damage of
he bacteria is induced by the direct contact of the bacteria withf Ag-GQDs at (A) C1s. (B) Ag3d.
the extremely sharp edges of the nanowalls [15]. In this study,
Escherichia coli bacteria with its outer membrane showed more
resistance to the cell membrane damage caused by the nanowalls
than S. aureus, which are lacking the outer membrane. This mech-
anism may  explain the lower resistance of S. aureus to Ag-GQDs
as compared to P. aeruginosa. Chook et al. reported that there is
an enhancement in the antibacterial activity of reduced graphene
oxide/silver nanocomposites due to an increase in the electron
transfer rate from Ag-NPs to reduced graphene oxide, leading
to the formation of partially positively charged Ag-NPs, which
can enhance the inhibition effect [35]. This mechanism is sup-
ported by the XPS data obtained above that show a charge transfer
between GQDs and Ag-NPs in Ag-GQDs nanocomposites. Marslin
et al. reported that PEG facilitate the entry of nanoparticles carry-
ing antibiotics, enhance the binding of the delivered drug to the
bacterial DNA and block drug efﬂux pumps [55]. Since Ag-GQDs
are PEGylated, it is possible that PEG enhance the entry of Ag-
GQDs inside bacterial cells inhibition due to increasing of binding of
DNA to silver. Another study suggested that the main advantage of
silver–carbon nanostructures is to effectively stabilize Ag-NPs and
prevent them from aggregation, which is a factor that greatly affects
the effectiveness of Ag-NPs’ antibacterial activities [63]. One or
more of the above-described mechanisms may  be simultaneously
taking place to produce the synergistic antibacterial effect of Ag-
GQDs.
3.4. Evaluation of cell viability in mammalian cells
We tested the cell viability of normal mammalian cells (i.e., Vero
cells) treated with Ag-GQDs, bare GQDs and bare Ag-NPs at the
same concentrations used in the antibacterial activity tests after
24 h of incubation (Fig. 4A). The results show that cell viability
was maintained at 100% for cells incubated with Ag-GQDs and bare
GQDs for all the concentrations tested. Nevertheless, bare Ag-NPs
have demonstrated a reduction in the cell viability for increasing
concentrations. A 30% reduction in the cell viability was observed
at a concentration of 150 g/mL. Our results suggest that the deco-
ration of Ag-NPs with GQDs may  minimize the toxicity associated
with silver nanoparticles.
Moreover, we have evaluated the cell viability of Ag-GQDs in
two additional cells lines of human carcinoma (i.e., HeLa and Jurkat
cells). In HeLa cells, the cell viability remained at 100% for all the
tested concentrations (see Fig. 4B). While testing the cell viability
of Jurkat cells in the presence of Ag-GQDs we observed that cells
maintained close to 100% for the bacterial MIC  concentrations (25
and 50 g/mL), however, a 50% reduction in the cell viability has
been observed when a concentration of 150 g/mL was used. It
was reported by Eom et al. that Jurkat cells in particular are very
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ndependent experiments.
ensitive to Ag-NPs due to the activation of p38 MAPK, DNA dam-
ge, cell cycle arrest and apoptosis, and they report an almost 100%
eduction in their viability when a concentration of 1 g/mL was
sed [64]. This result indicates that coating the Ag-NPs with GQDs
s an effective way to reduce their toxicity to mammalian cells.
. Conclusions
We  successfully synthesized biocompatible nanocomposites of
g-GQDs consisting of Ag-NPs decorated with GQDs on their sur-
ace and functionalized with PEG. The Ag-GQDs showed enhanced
ntibacterial activity against P. aeruginosa and S. aureus bacteria,
hich are used as Gram-negative and Gram-positive model bacte-
ia, respectively. The results showed that the decoration of Ag-NPs
ith GQDs fosters a synergistic effect and reduces dramatically
he concentrations required to inhibit both bacterial strains, which
re commonly isolated from microbial infections in wounds. The
ffective antibacterial concentrations of Ag-GQDs did not affect
he viability of human and animal cells, which suggest that they
re biocompatible and ecofriendly. These results also suggest that
g-GQDs nanocomposites may  be applied as antibacterial material,
uch as in: antibiotics, coating of surgical instrumentation, wound
ressing textiles, disinfectants, antiseptic and detergents. Further
tudies are necessary in order to elucidate the exact mechanism(s)
f Ag-GQDs that induce bacterial cytotoxicity.
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